Research Article
Treatment Outcomes in Anaplastic Thyroid Cancer
Table 2
Surgical, radioactive iodine, radiotherapy, and systemic treatment characteristics.
| | All patients (N=28) |
| Surgery | | No | 8 (28.6%) | Yes | 20 (71.4%) |
| Number of surgeries per patient | | 0 | 8 (28.6%) | 1 | 14 (50.0%) | 2 | 4 (14.3%) | 4 | 2 (7.1%) |
| Type(s) of surgery | | Lobectomy | 7 (25.0%) | Thyroidectomy | 12 (42.9%) | Lymph node dissection | 9 (32.1%) | Metastasectomy | 1 (3.6%) |
| Radioactive iodine | | No | 24 (85.7%) | Yes, after ATC diagnosis | 2 (7.1%) | Yes, before ATC diagnosis | 2 (7.1%) |
| EBRT to any site | | No | 7 (25.0%) | Yes | 21 (75.0%) |
| EBRT to thyroid bed/neck | | No | 9 (32.1%) | Yes | 19 (67.9%) |
| Total radiation dose (cGy) | | < 4,000 | 11 (39.3%) | ≥ 4,000 | 6 (21.4%) | Unknown | 4 (14.3%) |
| Radiation fractionation (fractions/day) | | 1 | 8 (28.6%) | > 1 | 9 (32.1%) | Unknown | 4 (14.3%) |
| More than one EBRT treatment course | | No | 19 (67.9%) | Yes | 9 (32.1%) |
| EBRT initial intent | | No EBRT | 7 (25.0%) | Palliative | 14 (50.0%) | Curative | 7 (25.0%) |
| EBRT initial technique | | No EBRT | 7 (25.0%) | 2D | 4 (14.3%) | 3D | 3 (10.7%) | IMRT/VMAT | 12 (42.9%) | Unknown | 2 (7.1%) |
| Systemic therapy | | No | 14 (50.0%) | Yes | 14 (50.0%) |
| Type(s) of chemotherapy used with EBRT | | Doxorubicin | 4 (14.3%) | Doxorubicin, Cisplatin | 2 (7.1%) | Doxorubicin, Carboplatin, Paclitaxel | 1 (3.6%) | Doxorubicin, Carboplatin, Paclitaxel, Cisplatin, Pemetrexed, Bevacizumab | 1 (3.6%) | Doxorubicin, Carboplatin, Paclitaxel, Cyclophosphamide, Vinorelbine, Gemcitabine | 1 (3.6%) | Carboplatin, Paclitaxel | 1 (3.6%) | Sorafenib | 1 (3.6%) |
| All treatments | | Surgery + EBRT + Chemotherapy | 10 (35.7%) | Surgery + EBRT | 5 (17.9%) | EBRT + Chemotherapy | 3 (10.7%) | EBRT only | 3 (10.7%) | Surgery only | 5 (17.9%) | Chemotherapy only | 1 (3.6%) | No treatment | 1 (3.6%) |
|
|
Counts and column percentages are presented unless otherwise specified. EBRT = external beam radiation therapy; IMRT = intensity modulated radiation therapy; VMAT = volumetric modulated arc therapy.
|